Thomas E. Tarara
39Patents
17h-index
40Co-inventors
81Inventor score
Filing activity: Feb 28, 1995 → Sep 20, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5874481A | Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents | Human Necessities | 174 | Expired |
| US6565885B1 | Methods of spray drying pharmaceutical compositions | Emerging Cross-Sectional Technologies | 163 | Expired |
| US6309623A | Stabilized preparations for use in metered dose inhalers | Emerging Cross-Sectional Technologies | 154 | Expired |
| US7306787B2 | Engineered particles and methods of use | Emerging Cross-Sectional Technologies | 117 | Expired |
| US5733526A | Hydrocarbon oil/fluorochemical preparations and methods of use | Emerging Cross-Sectional Technologies | 111 | Expired |
| US6630169B1 | Particulate delivery systems and methods of use | Emerging Cross-Sectional Technologies | 107 | Expired |
| US5667809A | Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents | Human Necessities | 105 | Expired |
| US7368102B2 | Pulmonary delivery of aminoglycosides | Human Necessities | 94 | Expired |
| US6433040B1 | Stabilized bioactive preparations and methods of use | Emerging Cross-Sectional Technologies | 89 | Expired |
| US6946117B1 | Stabilized preparations for use in nebulizers | Emerging Cross-Sectional Technologies | 66 | Expired |
| US5798091A | Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement | Human Necessities | 48 | Expired |
| US6638495B2 | Stabilized preparation for use in metered dose inhalers | Emerging Cross-Sectional Technologies | 42 | Expired |
| US7442388B2 | Phospholipid-based powders for drug delivery | Human Necessities | 25 | Expired |
| US7628978B2 | Stabilized preparations for use in metered dose inhalers | Emerging Cross-Sectional Technologies | 22 | Expired |
| US7205343B2 | Stabilized bioactive preparations and method of use | Emerging Cross-Sectional Technologies | 19 | Expired |
| US7393544B2 | Dispersion for pulmonary delivery of a bioactive agent | Emerging Cross-Sectional Technologies | 19 | Active |
| US7790145B2 | Respiratory dispersion for metered dose inhalers | Emerging Cross-Sectional Technologies | 18 | Active |
| US9439862B2 | Phospholipid-based powders for drug delivery | Human Necessities | 15 | Active |
| US8246934B2 | Respiratory dispersion for metered dose inhalers comprising perforated microstructures | Emerging Cross-Sectional Technologies | 14 | Active |
| US8168223B1 | Engineered particles and methods of use | Emerging Cross-Sectional Technologies | 14 | Expired |
| US8080263B2 | Dispersion for pulmonary delivery of a bioactive agent | Emerging Cross-Sectional Technologies | 7 | Active |
| US7326691B2 | Compositions comprising amphotericin B, methods, and systems | Human Necessities | 7 | Expired |
| US6280705A | Kits & systems for ultrasonic imaging | Human Necessities | 6 | Expired |
| US7871598B1 | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use | Human Necessities | 5 | Expired |
| US7141235B2 | Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement | Human Necessities | 3 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.